US2021139986A1PendingUtilityA1

Compositions and methods for enhancing odorant receptor activity

Assignee: UNIV DUKEPriority: Dec 4, 2009Filed: Dec 31, 2020Published: May 13, 2021
Est. expiryDec 4, 2029(~3.4 yrs left)· nominal 20-yr term from priority
C12Q 2600/156C12Q 1/6881C12Q 2600/136C07K 14/70571
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to polypeptides capable of modulating odorant receptor activation. In particular, the present invention provides polypeptides (e.g., type 3 muscarinic actetylcholine receptor M3) capable of enhancing odorant receptor activation. The present invention further provides assays for the detection of ligands specific for various odorant receptors. Additionally, the present invention provides methods of screening for polypeptide polymorphisms and mutations associated with odorant receptor activation (e.g., polymorphisms and mutations associated with muscarinic actetylcholine receptor polypeptides (e.g., M1, M2, M3, M4, M5)), as well as methods of screening for therapeutic agents, ligands, and modulators of such proteins.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A method of increasing odorant receptor activity in a heterologous cell system comprising expressing in heterologous cells heterologous nucleic acid encoding an odorant receptor, and a mammalian M3 muscarinic acetylcholine receptor in combination with a heterologous nucleic acid encoding a mammalian RTP1S protein.

Join the waitlist — get patent alerts

Track US2021139986A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.